GlassScriptPhysician profile
David Kuten
NPI 1881993236
$2,375.99
in general payments reported to CMS, 2019-2025
17 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $297 · 2021: $333 · 2022: $641 · 2023: $121 · 2024: $229 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $399.91 | 2019-2025 | Avvigo Guidance System |
| Abiomed | $307.94 | 2022-2025 | |
| Medtronic, INC. | $265.44 | 2021-2022 | |
| Biosense Webster, INC. | $199.95 | 2021-2024 | Carto 3 |
| Abbott Laboratories | $163.18 | 2022-2024 | Confirm Rx |
| Biotronik INC. | $142.58 | 2020 | |
| Edwards Lifesciences Corporation | $139.18 | 2021-2022 | |
| Medtronic Vascular, INC. | $139.10 | 2019 | |
| Amgen INC. | $128.39 | 2019 | |
| Pfizer INC. | $125.00 | 2020 | |
| Inari Medical, INC. | $112.02 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $106.78 | 2019-2021 | |
| Surmodics, INC. | $51.08 | 2024 | Pounce Thrombectomy |
| Terumo Medical Corporation | $40.34 | 2022 | |
| Shockwave Medical, INC | $32.63 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avinger INC. | $14.12 | 2020 | |
| Cardiovascular Systems INC. | $8.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kuten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.